<DOC>
	<DOCNO>NCT00587041</DOCNO>
	<brief_summary>The purpose study determine effect two probiotic preparation ( Agri-King Synbiotic Oxadrop ) urinary oxalate excretion patient mild hyperoxaluria . Probiotics live microorganism think beneficial host organism . Hyperoxaluria hereditary disorder cause special kind stone form kidney urine . Oxalates naturally-occurring substance find plant , animal , human . Excretion oxalates urine risk factor kidney stone formation . Our hypothesis mild hyperoxaluria due absorption oxalate food probiotic improve gastrointestinal barrier function decrease oxalate absorption across gut ( hence elimination urine ) . In study , participant randomize placebo , Agri-King Synbiotic , Oxadrop , treat 6 week . Patients maintain control diet remove confound variable differ oxalate intake availability food .</brief_summary>
	<brief_title>Use Oral Probiotics Reduce Urinary Oxalate Excretion</brief_title>
	<detailed_description>Renal manifestation chronic hyperoxaluria include nephrolithiasis , extreme , interstitial scar progressive loss function . The clinical outcome dismal . Although primary hyperoxaluria relatively rare , hyperoxaluria secondary gastrointestinal malabsorption . Furthermore , formation calcium oxalate kidney stone extremely common , evidence suggest minimal , perhaps transient elevation urinary oxalate concentration may important factor least subgroup patient `` idiopathic '' calcium oxalate urolithiasis . In case enteric hyperoxaluria pathogenic role oxalate clear , renal scar commonly observe consequence oxalate exposure calcium oxalate crystal deposition , addition stone . Unfortunately , satisfactory specific treatment enteric hyperoxaluria available . Typical strategy include dietary restriction oxalate limit delivery colon ; low fat diet limit malabsorption distal colonic effect fatty acid bile acid ; oral calcium bind oxalate ; bile acid sequestrants like cholestyramine . In entirety , regimen quite rigorous patient , even compliance achieve therapy always effective . Previous study show component endogenous digestive microflora utilize oxalate , potentially limit absorption intestinal lumen . A recent preliminary study demonstrate preparation lactic acid bacteria degrade oxalate vitro reduce urinary oxalate excretion give mouth . We recently demonstrate preparation lactic acid bacillus ( Oxadrop ) reduce urinary oxalate excretion patient enteric hyperoxaluria . In current proposal , placebo-controlled trial determine effectiveness another probiotic preparation ( Agri-King Synbiotic ) [ AKSB ] treatment hyperoxaluria patient mild hyperoxaluria , well enteric hyperoxaluria . Specific Aims : 1 ) Determine effect two probiotic preparation ( AKSB Oxadrop urinary oxalate excretion well-defined group patient enteric hyperoxaluria ; 2 ) Determine effect two probiotic preparation ( AKSB Oxadrop ) urinary oxalate excretion well-defined group patient idiopathic calcium oxalate urolithiasis mild hyperoxaluria . If result positive , treatment calcium oxalate kidney stone could revolutionize .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<criteria>Enteric hyperoxaluria ( &gt; 0.5 mM/day ; &gt; 45 mg/day ) due fat malabsorption inflammatory bowel disease ( Crohn 's Disease ) . ( Patients remission maintain stable dos Remicade/Imuran/Methotrexate every 8 week recruit long trial conduct 5 8 week last dose ) ; OR Enteric hyperoxaluria ( &gt; 0.5 mM/day ; &gt; 45 mg/day ) gastric bypass procedure ( gastric bypass obesity , surgical cause gastric dump fat malabsorption ( e.g. , antrectomy , vagotomy pyloroplasty gastric ulcer ) ( Patients inflammatory bowel disease must clinical remission ) ; OR Calcium oxalate nephrolithiasis mild hyperoxaluria unknown etiology ( &gt; 0.35 mM/day ) ( n=60 ) Presence radioopaque stone xray , history consistent passage stone stone surgery extracorporeal shock wave lithotripsy ( ESWL ) last 5 year stone medication , dos remain stable least 3 month Stone composition confirm either stone analysis demonstrate composition equal 50 % calcium oxalate , radiographic demonstration calcific renal stone presence hyperoxaluria On immunosuppressive medication ( exclude small stable dos prednisone 10 mg less ) Human immunodeficiency virus ( HIV ) infection , know enteric bacterial infection , history splenectomy Have current malignancy , superficial skin cancer excise , unless felt complete remission ( &gt; 5 year ) Previous colectomy Have complete course oral parenteral antibiotic le 2 week initiation study ( patient require course antibiotic period preparation administration withdrawn study exclude final analysis ) Patient pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Synbiotic</keyword>
	<keyword>Urine Oxalate</keyword>
	<keyword>Probiotic</keyword>
	<keyword>Kidney Stone</keyword>
	<keyword>Gastric Bypass</keyword>
	<keyword>Crohn 's</keyword>
	<keyword>Stone</keyword>
	<keyword>Hyperoxaluria</keyword>
	<keyword>Enteric Hyperoxaluria</keyword>
</DOC>